gelisse 50 mikrog/ g
italfarmaco s.a. - Østriol - vaginalgel - 50 mikrog/ g
lenzetto 1.53 mg/ spray
gedeon richter plc - Østradiolhemihydrat - transdermalspray, oppløsning - 1.53 mg/ spray
sequidot 50 mikrog / 250 mikrog
sandoz a/s - Østradiolhemihydrat / noretisteronacetat - depotplaster - 50 mikrog / 250 mikrog
trisekvens -
novo nordisk a/s - Østradiolhemihydrat / noretisteronacetat - tablett, filmdrasjert - 2 mg / 1 mg
vagifem 10 mikrog
novo nordisk a/s - Østradiolhemihydrat - vaginaltablett - 10 mikrog
symkevi
vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cystisk fibrose - andre åndedrettsprodukter - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.
femoston 2 mg / 10 mg
viatris healthcare ltd. - Østradiolhemihydrat / dydrogesteron - tablett, filmdrasjert - 2 mg / 10 mg
femoston 1 mg / 10 mg
viatris healthcare ltd. - Østradiolhemihydrat / dydrogesteron - tablett, filmdrasjert - 1 mg / 10 mg
femostonconti 1 mg / 5 mg
viatris healthcare ltd. - Østradiolhemihydrat / dydrogesteron - tablett, filmdrasjert - 1 mg / 5 mg
femostonconti 0.5 mg / 2.5 mg
viatris healthcare ltd. - Østradiolhemihydrat / dydrogesteron - tablett, filmdrasjert - 0.5 mg / 2.5 mg